while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..

in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..

elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital..

the longest one patient waited for treatment following a gp referral in 2017 was 541 days - against a target of 62 days.. september 2007  (27).